Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Medtronic
Chinese Patent Office
AstraZeneca
Express Scripts
Federal Trade Commission
Accenture
McKesson
Teva

Generated: June 24, 2018

DrugPatentWatch Database Preview

ATRACURIUM BESYLATE PRESERVATIVE FREE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Atracurium Besylate Preservative Free, and when can generic versions of Atracurium Besylate Preservative Free launch?

Atracurium Besylate Preservative Free is a drug marketed by Aurobindo Pharma Ltd, Baxter Hlthcare, Baxter Hlthcare Corp, Hospira, Hospira Inc, Mylan Labs Ltd, Nanjing King-friend, Watson Labs Inc, and West-ward Pharms Int. and is included in eleven NDAs.

The generic ingredient in ATRACURIUM BESYLATE PRESERVATIVE FREE is atracurium besylate. There are sixteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.
Summary for ATRACURIUM BESYLATE PRESERVATIVE FREE
Drug patent expirations by year for ATRACURIUM BESYLATE PRESERVATIVE FREE
Pharmacology for ATRACURIUM BESYLATE PRESERVATIVE FREE
Medical Subject Heading (MeSH) Categories for ATRACURIUM BESYLATE PRESERVATIVE FREE
Synonyms for ATRACURIUM BESYLATE PRESERVATIVE FREE
2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester
2-(2-CARBOXYETHYL)-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-1-VERATRYLISOQUINOLINIUM BENZENESULFONATE,PENTAMETHYLENE ESTER
2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) benzenesulfonate
2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium] Dibenzenesulfonate
2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-Isoquinolinium, dibenzenesulfonate (9CI); Atracurium besilate; Atracurium besylate; Atracurium
2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-[(3,4-DIMETHOXYPHENYL)METHYL]]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-ISOQUINOLINIUM, BENZENESULFONATE (1:2)
2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-[3,4-DIMETHOXYPHENYL)METHYL]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYLISO
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-{[3,4-bis(methyloxy)phenyl]methyl}-2-methyl-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
33 A 74
40AX66P76P
64228-79-1 (Parent)
64228-81-5
A834680
AB07163
AB1004899
AC1L2HUI
AKOS015895831
Ambap64228-79-1
AN-15362
AN-6664
AS-14131
Atracurii besilas
Atracurii besilas [INN-Latin]
Atracurium (besylate)
Atracurium besilate
Atracurium besilate (INN)
Atracurium besilate [INN]
Atracurium besylate
Atracurium besylate (USP)
Atracurium besylate [USAN:BAN]
Atracurium besylate [USAN:USP]
Atracurium besylate, >=98% (HPLC), powder
Atracurium besylate, European Pharmacopoeia (EP) Reference Standard
Atracurium besylate, mixture of isomers
Atracurium besylate, United States Pharmacopeia (USP) Reference Standard
atracurium dibenzenesulfonate
Atracurium for impurity F identification, European Pharmacopoeia (EP) Reference Standard
Atracurium for peak identification, European Pharmacopoeia (EP) Reference Standard
benzenesulfonate; 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoic acid 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-
benzenesulfonate; 5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1S,2S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H
benzenesulfonate; 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-i
benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-di
Besilate d'atracurium
Besilate d'atracurium [INN-French]
Besilato de atracurio
Besilato de atracurio [INN-Spanish]
BW 33 A
BW 33A
BW-33A
BW-33A BESYLATE
C53H72N2O12
C65H82N2O18S2
CA0147
CAS-64228-81-5
CCG-213566
CHEBI:2915
CHEMBL1200527
Cisatracuriumbesylate
CS-2306
D00758
DB00732
DSSTox_CID_2630
DSSTox_GSID_22630
DSSTox_RID_76665
DTXSID6022630
EINECS 264-743-4
FT-0659516
HMS1568A11
HMS2095A11
HMS3651C21
HY-B0292A
hydro-1H-isoquinolin-2-ium-2-yl]propanoate
I06-1457
I14-0811
Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate
ISOQUINOLINIUM,2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-(3,4-DIMETHOXYPHENYL)METHYL]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-,DIBENZENESULFONATE
K027
KS-00000L5H
LETROZOLEX
LP101934
LS-176358
MolPort-003-940-284
NC00429
NCGC00017127-01
NCGC00262598-01
NCGC00262598-02
NSC-760047
NSC760047
Pentamethylen bis(3-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-2-methyl-2-isochinolyl)propionat) bis(benzolsulfonat)
PENTAMETHYLENE BIS(3-(1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-1-(3,4-DIMETHOXYBENZYL)-2-METHYL-2-ISOCHINOLYL)PROPIONATE)BIS(BENZOLSULFONATE)
Pharmakon1600-01505872
PubChem3018
Q-101018
Q-200864
SCHEMBL41251
SR-01000781272
SR-01000781272-3
TL8004537
Tox21_110790
Tracrium
Tracrium (TN)
TRACRIUM BESYLATE
Tracrium Preservative Free
UNII-40AX66P76P
XXZSQOVSEBAPGS-UHFFFAOYSA-L

US Patents and Regulatory Information for ATRACURIUM BESYLATE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 206010-001 Apr 8, 2015 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 090782-001 Oct 18, 2012 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074633-001 Dec 23, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 206001-001 Apr 7, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Moodys
Johnson and Johnson
Mallinckrodt
AstraZeneca
QuintilesIMS
Boehringer Ingelheim
Covington
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.